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The coronavirus disease 2019 (COVID-19) has swept across all countries in the world within half a year, which 
is taking the world by surprise. We reported an elderly, severe, complicated COVID-19 case, describing the 
clinical manifestations, laboratory examinations, CT findings, diagnosis, treatment and dynamic disease course. 
3D post-processing technique was used to reconstruct different pulmonary lesions, and it was found to be useful 
for highlighting and observing them, thereby helping diagnose and distinguish different diseases. 
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Introduction 
The coronavirus disease 2019 (COVID-19) has been 
declared as a Public Health Emergency of International 
Concern (PHEIC) by World Health Organization (WHO)[1-4]. 
The elderly and patients with chronic underlying diseases tend 
to have severe conditions and poor prognosis[5]. We report an 
elderly, severe, complicated COVID-19 case, especially 
focusing on CT features and the role of 3D post-processing 
technology in diagnosis. 
Case Presentation 
A 85-year-old woman who visited Wuhan 14 days ago 
developed cough, phlegm, and loss of appetite on February 5, 
2020. By her own account, she had no special medical history. 
Three days later, she was admitted to hospital and received 
laboratory tests, which showed normal white blood cell count 
and lymphocyte count, elevated C-reactive protein (16.06 
mg/L; normal range: 0-5 mg/L) , increased erythrocyte 
sedimentation rate (54mm/h; normal range: 2-20.9 mm/h) and 
rised D-dimer level (8.63µg/ml; normal range: 0-1.5µg/ml).  
Plain chest CT revealed multiple patchy ground glass 
opacities in bilateral lungs, and three masses in the apical 
segment of right lung and the inferior lobe of both lungs 
(Figure 1). 3D post-processing images (CT post-processing  
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Figure 1. CT images in an elderly, severe, complicated COVID-19 patient. Transverse images reveal the dynamic 
changes of patchy peripheral ground glass opacities (white arrow) and three blocky shadows in the apical segment of 
right lung and the inferior lobe of both lungs. The exudation around the lesion in the apical of right upper lobe shows a 
tendency of increasing gradually and then absorption (red frame). The two mass shadows in the posterior segment of 
lower lobe of right lung (yellow frame) and the anteromedial basal segment of inferior lobe of left lung (green frame) 
present no significant dynamic changes. 
 
software, Syngo.via, Version VB20, Siemens Healthcare, 
Germany) clearly highlighted different foci in both lungs, 
including location, morphology, distribution, surrounding 
invasion, etc (Figure 2 and 3). The two blocky shadows in the 
apical segment of right upper lobe and the anteromedial basal 
segment of inferior lobe of left lung were considered to be 
chronic inflammatory lesions according to morphological 
characteristics. Although the mass in the posterior segment of 
lower lobe of right lung with lobulated shape, spicules of 
margin, and pleural indentation sign, may be malignant, she 
was too old and weak to undergo further needle biopsy or 
surgery to determine the nature of the lesion (Figure 2). A 
pharyngeal swab was positive for novel coronavirus on real-
time fluorescence polymerase chain reaction (RT-PCR) test, 
and she was diagnosed with severe COVID-19 due to low 
oxygen saturation (SPO2 <93%). Then she was isolated and 
given oxygen inhalation, moxifloxacin, and abedore treatment.  
After receiving 4 days of treatment, the patient's symptoms 
were relieved, but CT reexamination suggested progress, with 
enlarged peripheral patchy ground glass opacities and 
increased exudation around the lesion in the apical of right 
upper lobe (Figure 1). For the treatment, lopinavir/ritonavir 
and interferon were added. In the following 10 days, her D-
dimer level continued to rise, fluctuating at 22.88-48.14 μg/ml. 
Pulmonary vascular CTA showed no pulmonary embolism, 
lower limb vascular doppler ultrasound showed no venous 
thrombosis, and the patient had no no special discomfort. So 
clinicians considered the elevation of D-dimer to be associated 
with COVID-19 infection. However, during this period, two 
follow-up CT suggested reduced ground glass opacities, and 
three RT-PCR reexaminations were negative. On February 25, 
2020, the patient was transferred to the local COVID-19 
designated hospital for further treatment. 
Discussion 
Unenhanced CT examination is one of the major clinical 
diagnostic criteria for COVID-19 and plays an important role 
in early diagnosis, disease assessment and follow-up, because  
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Figure 2. CT images in an elderly, severe, complicated COVID-19 patient. A-C, Pseudocolor images of central layer of 
lesion highlight the morphological characteristics of the mass and its relationship with the adjacent pleura. The mass in the 
posterior segment of lower lobe of right lung has lobulated shape, short thorn and vessel convergence, involving the posterior 




Figure 3. 3D post-processing CT images in an elderly, severe, complicated COVID-19 patient. 3D volume reconstruction 
and area growth technique simultaneously reveal normal lung tissue, pneumonic exudation and three mass shadows, not only 
helping to assess the extent and distribution of COVID-19 infection, but also highlighting the location and morphology of 
the three lumpy opacities. 
 
 
CT findings can indicate the progression of the disease[6]. 
However, there were two contradictions between clinic and 
CT imaging in the course of disease in the patient we reported. 
While her clinical symptoms were in remission, the CT scan 
showed more ground glass shadows and exudation. While her 
D-dimer level continued to rise (suggesting a worsening of the 
infection), follow-up CT revealed gradual absorption of 
lesions. Therefore, for the elderly patients and patients with 
chronic diseases, not only the disease is more serious and 
prognosis is worse, but also clinical manifestations and CT 
imaging may be inconsistent. For the elderly, severe and 
complicated patients, CT examination should not be solely 
relied on, but should be combined with clinical and laboratory 
examinations to further evaluate the disease changes. 
As demonstrated by Liu T, et al and Peng Liu, et al, 
sophisticated reconstruction algorithms could provide better 
visualization of pulmonary lesions in COVID-19 patients with 
radiologists [7,8]. The lung foci in the patient we reported were 
multiple and complex, but 3D post-processing technology 
clearly showed the distribution, morphological characteristics 
and surrounding invasion of the lesions. Taking the mass in 
the posterior segment of lower lobe of right lung as an example, 
the pseudocolor images of central layer of lesion highlighted 
the morphological characteristics of the mass and its 
relationship with the adjacent pleura. Lobulated shape, short 
thorn, vessel convergence, and the involvement of the 
posterior pleura and oblique fissure, highly suggested a 
possibility of malignancy. Further 3D volume reconstruction 
and area growth technique visually marked the position and 
shape of the three blocky shadows, which were clearly 
distinguished from the surrounding patchy ground glass 
opacities. Therefore, 3D post-processing techniques can help 
to display the distribution and characteristics of different 
lesions in complicated COVID-19 cases, thereby helping 
diagnose and differentiate the diseases. 
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